Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2025. Verfasst von Tatsiana Pukhalskaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Pathology, University of California, California, USA. Hauptthemen laut MEDLINE: Dermatitis, Exfoliative, Interleukin-13, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
Erythroderma is a dermatologic condition characterized by widespread red and scaly skin. The causes include, but are not limited to, psoriasis, eczema, drug eruptions, pityriasis rubra pilaris (PRP), and cutaneous T‐cell lymphoma. Most of these are typified by Type 2 (e.g., eczema) or Type 17 (e.g., psoriasis) immune activation. However, since the clinicopathologic features of erythroderma can be nonspecific, assays that determine the underlying immune activation status are desirable.
Methods
IL‐13 RNA in situ hybridization and IL‐36 immunohistochemistry were performed on 30 specimens of erythroderma, to ascertain Type 2 and Type 17 immune signatures, respectively.
Results
Specimens of erythrodermic psoriasis and PRP showed strong expression of IL‐36 and less than one IL‐13‐positive cell per millimeter. Conversely, those of spongiotic dermatitis showed low expression of IL‐36 and greater than one IL‐13‐positive cell per millimeter. Most specimens of spongiotic, psoriasiform dermatitis demonstrated low IL‐36 expression and greater than one IL‐13‐positive cell per millimeter, but a subset showed high IL‐36 expression and greater than one IL‐13‐positive cell per millimeter.
Conclusions
We developed a Type 2/17 immune signature classifier based on cytokine profiling, which showed that cases of erythroderma fall within distinct categories of immune activation. This categorization may have utility in guiding clinical decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Pathology, University of California, California, USA.
- Cooper Medical School of Rowan University, Camden, New Jersey, USA.
ORCID-Profile: Jeffrey P North, Jarish N Cohen
Zitieren
APA
Pukhalskaya, T., Finkelstein, M., Miyake-Caballero, D. A., Tetzlaff, M. T., North, J. P., & Cohen, J. N. (2025). Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14775
Vancouver
Pukhalskaya T, Finkelstein M, Miyake-Caballero DA, Tetzlaff MT, North JP, Cohen JN. Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14775
BibTeX
@article{Pukhalskaya2025,
author = {Pukhalskaya, Tatsiana and Finkelstein, Mitchell and Miyake-Caballero, Dacia A and Tetzlaff, Michael T and North, Jeffrey P and Cohen, Jarish N},
title = {Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14775}
}
EUVIMED